Akari Therapeutics PlcのRSI
Akari Therapeutics PlcのRSIは何ですか。
Akari Therapeutics PlcのRSIは47.45です。
RSIの定義は何ですか。
相対力指数 (The relative strength index, RSI 14)は、一定期間における損益の規模を比較して、証券の価格変動の速度と変動を測る指標です。
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
NASDAQのセクタHealth CareにおけるRSIの企業と比べるAkari Therapeutics Plc
Akari Therapeutics Plcは何をしますか。
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Akari Therapeutics Plcと類似のrsi
- UBS ETF (CH) - SBI Domestic Government 1-3のRSIは47.43です。
- Inspiration Healthcare plcのRSIは47.43です。
- Kerr MinesのRSIは47.44です。
- Firsthand Technology Value Fund IncのRSIは47.44です。
- Rogers CommunicationsのRSIは47.44です。
- St. Augustine Gold and CopperのRSIは47.44です。
- Akari Therapeutics PlcのRSIは47.45です。
- Ultra PetroleumのRSIは47.46です。
- Gett Gold IncのRSIは47.46です。
- Zacatecas SilverのRSIは47.46です。
- CK InfrastructureのRSIは47.46です。
- Siemens AGのRSIは47.46です。
- Jia limitedのRSIは47.46です。